PATENT CLAIM ANALYSIS

Application Number: 15780134
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "341000"]

Abstract:
The present invention provides a compound of Formula I and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma kallikrein.

Claim (Index 7):
The compound of  claim 1  wherein R 3  is phenyl, thiophenyl or indazolyl, wherein said phenyl, thiophenyl and indazolyl groups are optionally substituted with C(O)OR 4 , C(O)NR 4 R 5 , NR 4 R 5 , NHC(O)OR 4 , NHC(O)C 1-4 alkyl-OR 4 ; or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.44737
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15771538', '15116576', '15329609', '15312839', '15329634']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8130365607738242
- 35 USC 102 Novelty (BERT): 0.5688848046056584
- Combined Prediction Score: 0.7886213851570076
- Mean Citation Score: 442.1717540000001
- Max Citation Score: 450.88834
- Similarity Product: 364.2712707119227

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test